Genky DrugStores Co., Ltd.
9267.T · JPX
9/30/2025 | 6/30/2025 | 6/20/2025 | 3/31/2025 | |
|---|---|---|---|---|
| Revenue | ¥56,042,000 | ¥53,403,000 | – | ¥48,625,000 |
| % Growth | 4.9% | – | – | – |
| Cost of Goods Sold | ¥44,694,000 | ¥42,288,000 | – | ¥38,759,000 |
| Gross Profit | ¥11,348,000 | ¥11,115,000 | – | ¥9,866,000 |
| % Margin | 20.2% | 20.8% | – | 20.3% |
| R&D Expenses | ¥0 | ¥0 | – | ¥0 |
| G&A Expenses | ¥0 | ¥0 | – | ¥0 |
| SG&A Expenses | ¥8,431,000 | ¥8,297,000 | – | ¥7,622,000 |
| Sales & Mktg Exp. | ¥0 | ¥0 | – | ¥0 |
| Other Operating Expenses | ¥0 | ¥0 | – | ¥0 |
| Operating Expenses | ¥8,431,000 | ¥8,297,000 | – | ¥7,622,000 |
| Operating Income | ¥2,917,000 | ¥2,818,000 | – | ¥2,244,000 |
| % Margin | 5.2% | 5.3% | – | 4.6% |
| Other Income/Exp. Net | ¥39,000 | ¥39,000 | – | ¥79,000 |
| Pre-Tax Income | ¥2,956,000 | ¥2,857,000 | – | ¥2,323,000 |
| Tax Expense | ¥919,000 | ¥664,000 | – | ¥718,000 |
| Net Income | ¥2,037,000 | ¥2,193,000 | – | ¥1,605,000 |
| % Margin | 3.6% | 4.1% | – | 3.3% |
| EPS | 67.01 | 72.16 | – | 52.8 |
| % Growth | -7.1% | – | – | – |
| EPS Diluted | 66.79 | 72.01 | – | 52.72 |
| Weighted Avg Shares Out | 30,398 | 30,393 | – | 30,396 |
| Weighted Avg Shares Out Dil | 30,499 | 30,455 | – | 30,446 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥5,000 | ¥3,000 | – | ¥4,000 |
| Interest Expense | ¥62,000 | ¥64,000 | – | ¥44,000 |
| Depreciation & Amortization | ¥1,639,000 | ¥1,738,000 | – | ¥1,596,000 |
| EBITDA | ¥4,657,000 | ¥4,657,000 | – | ¥3,965,000 |
| % Margin | 8.3% | 8.7% | – | 8.2% |